Alan Melcher

26PUBLICATIONS

210CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Genomics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (26)

Sort by Publication Date:

|Jun 05, 2026

Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activity.

|Mar 06, 2026

Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy.

Winnie Fernando, Jarama Clucas, Alberto Rizzo

|Mar 03, 2026

Effects of oncolytic immunotherapy with RP1 (vusolimogene oderparepvec) on immune cells mediate responsiveness to anti-PD-1 via STING-mediated interferon signaling.

Victoria Roulstone, Joan Kyula, Elizabeth Appleton

|Oct 22, 2025

Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer.

Charleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev

|Sep 26, 2025

Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunity.

Andrew J Hayes, Emma J Davies, Michelle Wilkinson

|Aug 01, 2025

Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial.

Magnus T Dillon, Emmanuel C Patin, Kabir Mohammed

Pageof 5

Frequent Collaborators

15 joint publications

Kevin J Harrington

10 joint publications

Emmanuel Patin

7 joint publications

Shane Foo

7 joint publications

Victoria Roulstone

7 joint publications

Charleen Ml Chan Wah Hak

Pablo Nenclares

Antonio Rullan

Richard Vile

Jyoti S Choudhary

Malin Pedersen

Frequent Collaborators

15 joint publications

Kevin J Harrington

10 joint publications

Emmanuel Patin

7 joint publications

Shane Foo

7 joint publications

Victoria Roulstone